Wedge Capital Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,041
Closed -$263K 440
2021
Q4
$263K Sell
6,041
-662
-10% -$26K ﹤0.01% 364
2021
Q3
$210K Buy
+6,703
New +$264K ﹤0.01% 381
2021
Q2
Sell
-5,750
Closed -$216K 484
2021
Q1
$216K Sell
5,750
-5,535
-49% -$173K ﹤0.01% 489
2020
Q4
$305K Buy
+11,285
New +$290K ﹤0.01% 464
2017
Q3
Sell
-17,500
Closed -$563K 583
2017
Q2
$563K Buy
17,500
+900
+5% +$29.5K 0.01% 427
2017
Q1
$574K Buy
16,600
+2,386
+17% +$85.2K 0.01% 418
2016
Q4
$502K Buy
+14,214
New +$480K ﹤0.01% 430
2016
Q3
Sell
-15,066
Closed -$563K 579
2016
Q2
$563K Buy
15,066
+1,358
+10% +$51K 0.01% 395
2016
Q1
$554K Buy
+13,708
New +$511K 0.01% 412

Other funds holding ACH

Wedge Capital Management's ACH Position: Q1 2022 in Review

Wedge Capital Management sold out of Accendra Health (ACH) in Q1 2022, closing a stake of 6,041 shares — an estimated $263K sold.

Wedge Capital Management first reported a position in ACH in Q1 2016 and held it in 9 quarters. The position peaked at $574K in Q1 2017. 266 funds tracked by Wall St. Rank hold ACH as of Q1 2022.

  • Wedge Capital Management reported no remaining Accendra Health position as of Q1 2022 after selling out during the quarter.
  • Wedge Capital Management sold 6,041 Accendra Health shares in Q1 2022, an estimated $263K.
  • Wedge Capital Management first reported a position in Accendra Health in Q1 2016 and held it in 9 quarters.
  • Wedge Capital Management's Accendra Health position peaked at $574K in Q1 2017.
  • 266 funds tracked by Wall St. Rank held Accendra Health as of Q1 2022.

Based on Wedge Capital Management's 13F filing for Q1 2022, filed 12 Apr 2022.